Conserved Epitope Regions

Size: px
Start display at page:

Download "Conserved Epitope Regions"

Transcription

1 Conserved Epitope Regions R. Burke Squires Influenza Research Database ASV 2011, Minneapolis, MN

2 Influenza Research Database (IRD) NIAID BioinformaLcs Resource Center (BRC) Free, public resource Support development of Vaccines DiagnosLcs TherapeuLcs

3 MoLvaLon Influenza viruses evolve through compelng forces: Immune pressure Select for altered protein regions recognized by immune system Protein funclonal constraints Retain essenlal funclonality for effeclve virus replicalon and transmission. Ideal immunogen Protein regions that are both strong immune epitopes and funclonally constrained.

4 Data and Methods Data Influenza sequence data Imported into IRD from GenBank Experimentally determined epitopes Immune Epitope Database (IEDB) T cell, B Cell Polymorphism scores Pre- computed in IRD using in- house curalon pipeline Crooks, G.E., Hon, G., Chandonia, J.- M. & Brenner, S.E. WebLogo: a sequence logo generator. Genome Res. 14, (2004).

5 Data and Methods, cont. Workflow for Polymorphism Analysis in IRD Download pre- computed polymorphism scores for Human, H1N1 from IRD 0 2 / 5 = A B C A B C A B C AAC A B C A B C A B C A B C A B C A B A B C A B C A B C A B C A B C A B CCBBA B C A B C A B A B C A B C A B C A CCA B C A B C A BBA B C A B C A B Averaged polymorphism scores using a 5 amino acids window

6 Materials and Methods, cont. Workflow for Epitope PosiLon QuanLtaLon Download immune epitope metadata from IRD Compute epitope coverage score for each posilon 3 Influenza HA protein T cell epitope Graph polymorphism versus epitope coverage

7 Polymorphism Score Vs. Epitope Coverage!" #!" $!" %!" &!" '!!" '#!"!" #" $" %" &" '!" '#" '" '!" '(" #&" )*" $%" ++" %$" *)" &#" ('" '!!" '!(" ''&" '#*" ')%" '$+" '+$" '%)" '*#" '&'" '(!" '((" #!&" #'*" ##%" #)+" #$$" #+)" #%#" #*'" #&!" #&(" #(&" )!*" )'%" )#+" ))$" )$)" )+#" )%'" )*!" )*(" )&&" )(*" $!%" $'+" $#$" $))" $$#" $+'" $%!" $%("!"#$%"&'()*%+,-"&.+ /')0"'.+1"2.& !" #!" $!" %!" &!" '!!" '#!"!" #" $" %" &" '!" '#" '$" '%" '&" '" '#" #(" ($" $)" )%" %*" *&" &+" '!!" '''" '##" '((" '$$" '))" '%%" '**" '&&" '++" #'!" ##'" #(#" #$(" #)$" #%)" #*%" #&*" #+&" (!+" (#!" (('" ($#" ()(" (%$" (*)" (&%" (+*" $!&" $'+" $(!" $$'" $)#" $%(" $*$" $&)" $+%" )!*" )'&" )#+" )$!" ))'" )%#"!"#$%"&'()*%+,-"&.+ /')0"'.+1"2.& Polymorphism score - T cell epitope coverage - B cell epitope coverage

8 Scenarios Low Epitope Coverage High Epitope Coverage Conserved Epitope Regions Low Polymorphism (Func. Constained)) Immunodominance High Polymorphism Polymorphism (Avg.) T cell B cell

9 Conserved Epitope Regions Protein Regions HA (HA- CER1); (HA- CER2); (HA- CER3); (HA- CER4); (HA- CER5) NA (NA- CER1); (NA- CER2); (NA- CER3) M (M1- CER1) NS (NS1- CER1); (NS1- CER2); (NS1- CER3) PA (PA- CER1)

10 Conserved Epitope Regions!" #!" $!" %!" &!" '!!" '#!"!" #" $" %" &" '!" '#" '$" '%" '&" '" '#" #(" ($" $)" )%" %*" *&" &+" '!!" '''" '##" '((" '$$" '))" '%%" '**" '&&" '++" #'!" ##'" #(#" #$(" #)$" #%)" #*%" #&*" #+&" (!+" (#!" (('" ($#" ()(" (%$" (*)" (&%" (+*" $!&" $'+" $(!" $$'" $)#" $%(" $*$" $&)" $+%" )!*" )'&" )#+" )$!" ))'" )%#"!"#$%"&'()*%+,-"&.+ /')0"'.+1"2.& HemaggluLnin PDB ID: 1RUZ

11 ValidaLon Reference Region LocaJon H0 coord. CER coverage Eikert et al Broadly neutralizing anlbody (CR6261) Region 1 Broadly neutralizing anlbody (CR6261) Region 2 HA1 Val40 47 HA- CER1 HA1 Leu42 49 HA- CER1 HA1 Leu ? none HA2 Thr none HA2 Val HA- CER4 HA2 Ile HA- CER4 HA1 His18 25 HA- CER1 HA1 His38 45 HA- CER1 HA2 Trp HA- CER3 HA2 Thr none HA2 Ile none Wang et al D1 HA HA- CER5 Ekiert, D., et al., An#body recogni#on of a highly conserved influenza virus epitope. Science, (5924): p Wang, T., et al., Broadly protec#ve monoclonal an#bodies against H3 influenza viruses following sequen#al immuniza#on with different hemagglu#nins. PLoS Pathog, : p. e

12 Summary Conserved Epitope Regions (CERs) ULlizing the data from resources within the IRD Amino acids appear to be highly conserved in spite of immune recognilon Ideal vaccine would focus the immune response to protein regions that are both strong immune epitopes and funclonally constrained

13 Acknowledgments U.T. Southwestern Richard Scheuermann Jyothi Noronha Victoria Hunt Yun Zhang Brei Pickei Eva Rab MSSM Adolfo Garcia- Sastre Eric Bortz Gina Conenello Peter Palese Vecna Chris Larsen Al Ramsey LANL Catherine Macken Northrop Grumman Ed Klem Mike Atassi Jon Dietrich Wei Jen Sanjeev Kumar Xiaomei Li Jason Lucas Huarong Lu Jianjun Wang Liwei Zhou U.C. Davis Nicole Baumgarth USDA David Suarez CEIRS Centers NIAID N01AI40041 IRD SWG Gillian Air, OMRF Carol Cardona, Univ. Minnesota Adolfo Garcia- Sastre, Mt Sinai Elodie Ghedin, Univ. Piisburgh Martha Nelson, Fogarty Daniel Perez, Univ. Maryland Gavin Smith, Duke Singapore David Spiro, JCVI Dave Stallknecht, Univ. Georgia David Topham, Rochester Richard Webby, St Jude 13

14 Influenza Research Database (IRD) & Virus Pathogen Analysis Portal (ViPR) Drop by our exhibit booth in the lobby of the Radison Hotel!

Influenza Virus HA Subtype Numbering Conversion Tool and the Identification of Candidate Cross-Reactive Immune Epitopes

Influenza Virus HA Subtype Numbering Conversion Tool and the Identification of Candidate Cross-Reactive Immune Epitopes Influenza Virus HA Subtype Numbering Conversion Tool and the Identification of Candidate Cross-Reactive Immune Epitopes Brian J. Reardon, Ph.D. J. Craig Venter Institute breardon@jcvi.org Introduction:

More information

EVOLUTIONARY TRAJECTORY ANALYSIS: RECENT ENHANCEMENTS. R. Burke Squires

EVOLUTIONARY TRAJECTORY ANALYSIS: RECENT ENHANCEMENTS. R. Burke Squires EVOLUTIONARY TRAJECTORY ANALYSIS: RECENT ENHANCEMENTS R. Burke Squires Pandemic H1N1 2009 Origin? April / May 2009 Cases of an Influenza-like Illness (ILI) occurred in California, Texas and Mexico New

More information

Influenza IDO. Influenza Ontology

Influenza IDO. Influenza Ontology Influenza IDO Status January 2010 Influenza Ontology Developers Melanie Courtot, BCCRC Joanne Luciano, Predictive Medicine, Inc. Lynn Schriml, Univ. Maryland Burke Squires, Influenza Research Database

More information

Automated Quantification and Description of the Evolutionary Patterns of Influenza Viruses in U.S. Swine

Automated Quantification and Description of the Evolutionary Patterns of Influenza Viruses in U.S. Swine Automated Quantification and Description of the Evolutionary Patterns of Influenza Viruses in U.S. Swine Spatial dissemination of a novel H3 influenza A Swine influenza A epidemic peaks Influenza A virus

More information

SEQUENCE FEATURE VARIANT TYPES

SEQUENCE FEATURE VARIANT TYPES SEQUENCE FEATURE VARIANT TYPES DEFINITION OF SFVT: The Sequence Feature Variant Type (SFVT) component in IRD (http://www.fludb.org) is a relatively novel approach that delineates specific regions, called

More information

Bioinformatics and Comparative Genomics Applications

Bioinformatics and Comparative Genomics Applications Bioinformatics and Comparative Genomics Applications 12OCT2016 Richard H. Scheuermann, Ph.D. Director of Informatics - JCVI Outline Bioinformatics and the Big Data value proposition Viral database resources

More information

Hemagglutinin-stalk specific antibodies: How to induce them and how to measure them

Hemagglutinin-stalk specific antibodies: How to induce them and how to measure them Immunodominant head domain Stalk domain Hemagglutinin-stalk specific antibodies: How to induce them and how to measure them Florian Krammer Icahn School of Medicine at Mount Sinai May 5 th 2014 2 nd WHO

More information

Module 3. Genomic data and annotations in public databases Exercises Custom sequence annotation

Module 3. Genomic data and annotations in public databases Exercises Custom sequence annotation Module 3. Genomic data and annotations in public databases Exercises Custom sequence annotation Objectives Upon completion of this exercise, you will be able to use the annotation pipelines provided by

More information

Fondation Merieux J Craig Venter Institute Bioinformatics Workshop. December 5 8, 2017

Fondation Merieux J Craig Venter Institute Bioinformatics Workshop. December 5 8, 2017 Fondation Merieux J Craig Venter Institute Bioinformatics Workshop December 5 8, 2017 Module 5: Comparative Genomics Analysis Outline Definition of comparative genomics Applications in studying human pathogens

More information

ViPR SWG Meeting 17NOV2015

ViPR SWG Meeting 17NOV2015 ViPR SWG Meeting 17NOV2015 Introduction and Usage ViPR Development Team J. Craig Venter Institute Brian Aevermann Suman Das Doug Greer Alex Lee Brian Reardon Reed Shabman Lucy Stewart Tim Stockwell Yun

More information

Section D. Identification of serotype-specific amino acid positions in DENV NS1. Objective

Section D. Identification of serotype-specific amino acid positions in DENV NS1. Objective Section D. Identification of serotype-specific amino acid positions in DENV NS1 Objective Upon completion of this exercise, you will be able to use the Virus Pathogen Resource (ViPR; http://www.viprbrc.org/)

More information

a. From the grey navigation bar, mouse over Analyze & Visualize and click Annotate Nucleotide Sequences.

a. From the grey navigation bar, mouse over Analyze & Visualize and click Annotate Nucleotide Sequences. Section D. Custom sequence annotation After this exercise you should be able to use the annotation pipelines provided by the Influenza Research Database (IRD) and Virus Pathogen Resource (ViPR) to annotate

More information

Rotavirus Genotyping and Enhanced Annotation in the Virus Pathogen Resource (ViPR) Yun Zhang J. Craig Venter Institute ASV 2016 June 19, 2016

Rotavirus Genotyping and Enhanced Annotation in the Virus Pathogen Resource (ViPR) Yun Zhang J. Craig Venter Institute ASV 2016 June 19, 2016 Rotavirus Genotyping and Enhanced Annotation in the Virus Pathogen Resource (ViPR) Yun Zhang J. Craig Venter Institute ASV 2016 June 19, 2016 Loading Virus Pathogen Database and Analysis About Resource

More information

Predicting the future

Predicting the future Swine influenza A viruses: a more global picture Predicting the future Dr Nicola S. Lewis BSc BVetMed PhD MRCVS Dr Nicola S. Lewis BSc BVetMed PhD MRCVS Centre for for Pathogen Evolution and WHO Collaborating

More information

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University Broadly protective influenza vaccines for pandemic preparedness Suresh Mittal Department of Comparative Pathobiology Purdue University Influenza A Virus Orthomyxovirus Consist of s/s (-) sense RNA 8 segments

More information

TOWARDS A UNIVERSAL INFLUENZA VIRUS VACCINE

TOWARDS A UNIVERSAL INFLUENZA VIRUS VACCINE TOWARDS A UNIVERSAL INFLUENZA VIRUS VACCINE Peter Palese Icahn School of Medicine at Mount Sinai New York OPTIONS IX 8-26-16 ISIRV - Options IX for the Control of Influenza Peter Palese, PhD Professor

More information

Influenza Sequence Feature Variant Type (Flu-SFVT) analysis: evidence for a role of

Influenza Sequence Feature Variant Type (Flu-SFVT) analysis: evidence for a role of JVI Accepts, published online ahead of print on 7 March 2012 J. Virol. doi:10.1128/jvi.06901-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Influenza Sequence Feature Variant

More information

UNIVERSAL INFLUENZA VIRUS VACCINES Adolfo García Sastre. Icahn School of Medicine at Mount Sinai, New York

UNIVERSAL INFLUENZA VIRUS VACCINES Adolfo García Sastre. Icahn School of Medicine at Mount Sinai, New York UNIVERSAL INFLUENZA VIRUS VACCINES Adolfo García Sastre Icahn School of Medicine at Mount Sinai, New York INFLUENZA VIRUSES PAx B EPIDEMIOLOGY OF HUMAN INFLUENZA VIRUSES A H1N1 H3N2 1968 H2N2 1957 H1N1

More information

Cristina Cassetti, Ph.D.

Cristina Cassetti, Ph.D. NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID

More information

Human B Cell Responses to Influenza Virus Vaccination

Human B Cell Responses to Influenza Virus Vaccination Human B Cell Responses to Influenza Virus Vaccination Nucleoprotein (RNA) Influenza Virus Neuraminidase (NA) Hemagglutinin (HA) Enveloped, single-stranded, negative-sense RNA virus with segmented genome.

More information

Section B. Comparative Genomics Analysis of Influenza H5N2 Viruses. Objective

Section B. Comparative Genomics Analysis of Influenza H5N2 Viruses. Objective Section B. Comparative Genomics Analysis of Influenza H5N2 Viruses Objective Upon completion of this exercise, you will be able to use the Influenza Research Database (IRD; http://www.fludb.org/) to: Search

More information

OFFLU swine influenza virus meeting March 2017 FAO Headquarters, Rome, Italy. Amy Vincent USDA-ARS National Animal Disease Center

OFFLU swine influenza virus meeting March 2017 FAO Headquarters, Rome, Italy. Amy Vincent USDA-ARS National Animal Disease Center OFFLU swine influenza virus meeting 27 28 arch 217 FAO Headquarters, Rome, Italy Amy Vincent USDA-ARS National Animal Disease Center 1 USDA IAV-S Surveillance DC Quarterly Summary Q1FY17 H1 H3 Delta-1

More information

Summary of the OFFLU Swine Influenza Virus (SIV) Group Meeting University of Minnesota, Minneapolis, March 2014

Summary of the OFFLU Swine Influenza Virus (SIV) Group Meeting University of Minnesota, Minneapolis, March 2014 Summary of the OFFLU Swine Influenza Virus (SIV) Group Meeting University of Minnesota, Minneapolis, 19-20 March 2014 Participants: Amy Vincent (USA), Ariel Pereda (Argentina), Ian Brown (UK), Yohannes

More information

Technology Overview. Summary

Technology Overview. Summary Live Attenuated Influenza Vaccines with Altered NS1 Technology Overview Summary Transformative Technology: Live attenuated influenza vaccines (LAIVs) with precise, genetically stable truncations of the

More information

User Guide. Protein Clpper. Statistical scoring of protease cleavage sites. 1. Introduction Protein Clpper Analysis Procedure...

User Guide. Protein Clpper. Statistical scoring of protease cleavage sites. 1. Introduction Protein Clpper Analysis Procedure... User Guide Protein Clpper Statistical scoring of protease cleavage sites Content 1. Introduction... 2 2. Protein Clpper Analysis Procedure... 3 3. Input and Output Files... 9 4. Contact Information...

More information

Influenza Genome Sequencing Project Proposal

Influenza Genome Sequencing Project Proposal Date of Proposal (MM/DD/YY): 06/13/12 TITLE: Role of the Untranslated Regions of the Influenza A Virus Replication and Vaccines Purpose/Objective-please provide a brief one to two paragraph description

More information

Development of safe and immunogenic reassortant viruses with 5:3 genotype for live attenuated influenza vaccine

Development of safe and immunogenic reassortant viruses with 5:3 genotype for live attenuated influenza vaccine Development of safe and immunogenic reassortant viruses with 5:3 genotype for live attenuated influenza vaccine Irina Isakova-Sivak, PhD Institute of Experimental Medicine, Saint Petersburg, Russia The

More information

Antigenic diversity and evolution of swine influenza viruses: an update! OFFLU swine influenza virus group, Rome 2013! Department of Zoology

Antigenic diversity and evolution of swine influenza viruses: an update! OFFLU swine influenza virus group, Rome 2013! Department of Zoology Antigenic diversity and evolution of swine influenza viruses: an update! OFFLU swine influenza virus group, Rome 2013! Department of Zoology Initial OFFLU SIV antigenic cartography aim -> global antigenic

More information

NIAID Oversight of Clinical Research and Funding Opportunities

NIAID Oversight of Clinical Research and Funding Opportunities NIAID Oversight of Clinical Research and Funding Opportunities The Fundamentals of International Clinical Research Workshop Dar es Salaam, Tanzania Polly R. Sager, Ph.D. Division of Microbiology and Infectious

More information

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?

TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of

More information

Immunogenicity of Avian Influenza H7N9 Virus in Birds

Immunogenicity of Avian Influenza H7N9 Virus in Birds Immunogenicity of Avian Influenza H7N9 Virus in Birds Identification of Viral Epitopes Recognized by the Immune System Following Vaccination and Challenge Darrell R. Kapczynski US DEPARTMENT OF AGRICULTURE,

More information

Agricultural Outlook Forum Presented: February 16, 2006 ACTIVITIES AND COORDINATION TO ADDRESS HIGHEST PRIORITY GAPS

Agricultural Outlook Forum Presented: February 16, 2006 ACTIVITIES AND COORDINATION TO ADDRESS HIGHEST PRIORITY GAPS Agricultural Outlook Forum Presented: February 16, 2006 ACTIVITIES AND COORDINATION TO ADDRESS HIGHEST PRIORITY GAPS Daniel Perez Program Director, Prevention and Control of Avian Influenza In the United

More information

APPENDIX A. INVESTIGATOR: Rowland, R. PERFORMING INSTITUTION: KANSAS STATE UNIV MANHATTAN, KANSAS 66506

APPENDIX A. INVESTIGATOR: Rowland, R. PERFORMING INSTITUTION: KANSAS STATE UNIV MANHATTAN, KANSAS 66506 APPENDIX A Competitive federal funding by NIH or USDA AFRI to NC229 labs ( period 2014-2018). List compiled with CRIS system search [Date Search was conducted: December 18 2018, key words: swine and virus]

More information

Tool for Pandemic Influenza Risk Assessment (TIPRA) Presented by Gina Samaan Global Influenza Programme

Tool for Pandemic Influenza Risk Assessment (TIPRA) Presented by Gina Samaan Global Influenza Programme Tool for Pandemic Influenza Risk Assessment (TIPRA) Presented by Gina Samaan Global Influenza Programme Context Rapid Risk Assessment of Acute Public Health Events (WHO, 2012) Need for specific risk assessment

More information

The DBA.2 Mouse Is Susceptible to Disease following Infection with a Broad, but Limited, Range of Influenza A and B Viruses

The DBA.2 Mouse Is Susceptible to Disease following Infection with a Broad, but Limited, Range of Influenza A and B Viruses JOURNAL OF VIROLOGY, Dec. 2011, p. 12825 12829 Vol. 85, No. 23 0022-538X/11/$12.00 doi:10.1128/jvi.05930-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. The DBA.2 Mouse Is Susceptible

More information

Section B. Comparative Genomics Analysis of 2013 H7N9 Influenza A Viruses. Objective

Section B. Comparative Genomics Analysis of 2013 H7N9 Influenza A Viruses. Objective Section B. Comparative Genomics Analysis of 2013 H7N9 Influenza A Viruses Objective Upon completion of this exercise, you will be able to use the Influenza Research Database (IRD; http://www.fludb.org/)

More information

An Exploration to Determine if Fab Molecules are Efficacious in Neutralizing Influenza H1 and H3 Subtypes. Nick Poulton June September 2012

An Exploration to Determine if Fab Molecules are Efficacious in Neutralizing Influenza H1 and H3 Subtypes. Nick Poulton June September 2012 An Exploration to Determine if Fab Molecules are Efficacious in Neutralizing Influenza H1 and H3 Subtypes Nick Poulton June 2012- September 2012 Epidemiology of Influenza Infection Causes between 250,000

More information

Global antigenic cartography publication, ongoing cross H1 and H3 antigenic characterisation

Global antigenic cartography publication, ongoing cross H1 and H3 antigenic characterisation Global antigenic cartography publication, ongoing cross H1 and H3 antigenic characterisation OFFLU SIV Group technical meeting, 19-20 March 2014 University of Minnesota, Minneapolis, USA WHO Collaborating

More information

Emerging infectious disease: trends in the literature on SARS and H7N9 influenza

Emerging infectious disease: trends in the literature on SARS and H7N9 influenza Scientometrics (2015) 105:485 495 DOI 10.1007/s11192-015-1681-8 Emerging infectious disease: trends in the literature on SARS and H7N9 influenza Deqiao Tian 1 Tao Zheng 1 Received: 19 July 2015 / Published

More information

Risk Assessment of H3N2 Avian Origin Canine Influenza Viruses

Risk Assessment of H3N2 Avian Origin Canine Influenza Viruses Risk Assessment of H3N2 Avian Origin Canine Influenza Viruses Henry Wan, Ph.D. Department of Basic Sciences College of Veterinary Medicine Mississippi State University E-mail: wan@cvm.msstate.edu Phone:

More information

Emergence of Influenza A in Agricultural Fairs. Andrew S. Bowman, MS, DVM, PhD, DACVPM The Ohio State University

Emergence of Influenza A in Agricultural Fairs. Andrew S. Bowman, MS, DVM, PhD, DACVPM The Ohio State University Emergence of Influenza A in Agricultural Fairs Andrew S. Bowman, MS, DVM, PhD, DACVPM The Ohio State University Background Pigs play a critical role in the ecology and epidemiology of influenza A viruses

More information

Active and Passive Immunization for Avian Influenza Virus Infections

Active and Passive Immunization for Avian Influenza Virus Infections NIAID Active and Passive Immunization for Avian Influenza Virus Infections Kanta Subbarao, MD, MPH Laboratory of Infectious Diseases NIAID, NIH Immortalizing H5 HA-Specific Memory B Cells Collection of

More information

Immune Epitope Database NEWSLETTER Volume 6, Issue 2 July 2009

Immune Epitope Database NEWSLETTER Volume 6, Issue 2  July 2009 Immune Epitope Database NEWSLETTER Volume 6, Issue 2 http://www.iedb.org July 2009 In response to concerns of a swine flu epidemic, the IEDB Curation curation team updated the database s collection of

More information

Product Development for Public Health & Emerging Infections

Product Development for Public Health & Emerging Infections Product Development for Public Health & Emerging Infections Michael G Kurilla, MD-PhD Director, Office of BioDefense Research Affairs Division of Microbiology & Infectious Diseases Associate Director,

More information

Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC

Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention. June 18, 2015 NIBSC Workshop on Immunoassay Standardization for Universal Flu Vaccines Min Levine, Ph. D. Influenza Division US Centers for Disease Control and Prevention June 18, 2015 NIBSC 1 Multiple Immune Mechanisms Contribute

More information

7/14/2014 VACCINE-INDUCED ANTI-HA2 ANTIBODIES PROMOTE VIRUS FUSION AND ENHANCE INFLUENZA VIRUS RESPIRATORY DISEASE (VAERD)

7/14/2014 VACCINE-INDUCED ANTI-HA2 ANTIBODIES PROMOTE VIRUS FUSION AND ENHANCE INFLUENZA VIRUS RESPIRATORY DISEASE (VAERD) 7/14/214 VACCINATION & ENHANCED DISEASE VACCINE-INDUCED ANTI-HA2 ANTIBODIES PROMOTE VIRUS FUSION AND ENHANCE INFLUENZA VIRUS RESPIRATORY DISEASE (VAERD) HANA GOLDING & SURENDER KHURANA DIVISION OF VIRAL

More information

Bjoern Peters La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012

Bjoern Peters La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012 www.iedb.org Bjoern Peters bpeters@liai.org La Jolla Institute for Allergy and Immunology Buenos Aires, Oct 31, 2012 Overview 1. Introduction to the IEDB 2. Application: 2009 Swine-origin influenza virus

More information

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group) AIDS Vaccine 07, Seattle, August 20-23, 2007 EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV (Summary of the recommendations from an Enterprise Working Group) The Working Group Reston, Virginia,

More information

C E E Z A D. Rational Development of Influenza Vaccines: NDV-based influenza vaccines for poultry and livestock

C E E Z A D. Rational Development of Influenza Vaccines: NDV-based influenza vaccines for poultry and livestock C E E Z A D Center of Excellence for Emerging and Zoonotic Animal Diseases A Department of Homeland Security Center of Excellence Rational Development of Influenza Vaccines: NDV-based influenza vaccines

More information

The Influenza Virus Resource at the National Center for Biotechnology Information. Running Title: NCBI Influenza Virus Resource ACCEPTED

The Influenza Virus Resource at the National Center for Biotechnology Information. Running Title: NCBI Influenza Virus Resource ACCEPTED JVI Accepts, published online ahead of print on 17 October 2007 J. Virol. doi:10.1128/jvi.02005-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

Application of Reverse Genetics to Influenza Vaccine Development

Application of Reverse Genetics to Influenza Vaccine Development NIAID Application of Reverse Genetics to Influenza Vaccine Development Kanta Subbarao Laboratory of Infectious Diseases NIAID, NIH Licensed Vaccines for Influenza Principle: Induction of a protective

More information

Prospect of Universal Influenza Vaccine Designed by Broadly Neutralizing Monoclonal Antibodies (1) Yoshinobu Okuno

Prospect of Universal Influenza Vaccine Designed by Broadly Neutralizing Monoclonal Antibodies (1) Yoshinobu Okuno Vaccine World East Asia 2015 Seoul, January 26, 2015 Prospect of Universal Influenza Vaccine Designed by Broadly Neutralizing Monoclonal Antibodies (1) Yoshinobu Okuno The Research Foundation for Microbial

More information

Potential cross reactions between HIV 1 specific T cells and the microbiome. Andrew McMichael Suzanne Campion

Potential cross reactions between HIV 1 specific T cells and the microbiome. Andrew McMichael Suzanne Campion Potential cross reactions between HIV 1 specific T cells and the microbiome Andrew McMichael Suzanne Campion Role of the Microbiome? T cell (and B cell) immune responses to HIV and Vaccines are influenced

More information

U.S. Fish & Wildlife Service Avian Influenza

U.S. Fish & Wildlife Service Avian Influenza U.S. Fish & Wildlife Service Avian Influenza Be on the Lookout About Highly Pathogenic Avian Influenza H5N1 Avian influenza (AI), or bird flu, is caused by a variety of viruses commonly found in some species

More information

EMORY-UGA CENTER OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE

EMORY-UGA CENTER OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE EMORY-UGA CENTER OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE ATLANTA & ATHENS Principal Investigator Walter A. Orenstein, MD, Professor and Associate Director Emory Vaccine Center; Professor

More information

Characterizing intra-host influenza virus populations to predict emergence

Characterizing intra-host influenza virus populations to predict emergence Characterizing intra-host influenza virus populations to predict emergence June 12, 2012 Forum on Microbial Threats Washington, DC Elodie Ghedin Center for Vaccine Research Dept. Computational & Systems

More information

Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses

Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses JOURNAL OF VIROLOGY, May 2011, p. 4596 4601 Vol. 85, No. 9 0022-538X/11/$12.00 doi:10.1128/jvi.00029-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Impact of Amino Acid Mutations

More information

Influenzavirus. Influenzavirus 10/27/15. Lord Randolphs report from Queen Marys trip to Scotland in 1562

Influenzavirus. Influenzavirus 10/27/15. Lord Randolphs report from Queen Marys trip to Scotland in 1562 A disease under the influence of the stars or the moon. Lord Randolphs report from Queen Marys trip to Scotland in 1562 She fell acquaintance with a new disease which passed through her whole court neither

More information

ph1n1 H3N2: A Novel Influenza Virus Reassortment

ph1n1 H3N2: A Novel Influenza Virus Reassortment ph1n1 H3N2: A Novel Influenza Virus Reassortment Jonathan Gubbay Medical Microbiologist Public Health Laboratory Public Health Ontario June 16, 2011 ph1n1 H3N2 Reassortment: Talk Overview Explain strain

More information

Novel Flu Vaccines Lots of choices

Novel Flu Vaccines Lots of choices Novel Flu Vaccines Lots of choices Universal M2 ectodomain (A types, only) Universal HA cleavage site (A and B types) HA made by rdna methods (not eggs or mammalian cells) Vectored delivery of HA genes

More information

Clinical Trials of Pandemic Vaccines: Key Issues. John Treanor University of Rochester Rochester, NY

Clinical Trials of Pandemic Vaccines: Key Issues. John Treanor University of Rochester Rochester, NY Clinical Trials of Pandemic Vaccines: Key Issues John Treanor University of Rochester Rochester, NY Inactivated vaccine approach Proven technology Used successfully in 1957 and 1968 Abundant efficacy data

More information

FDA/CMS Vaccine Safety Projects Using Medicare Data

FDA/CMS Vaccine Safety Projects Using Medicare Data FDA/CMS Vaccine Safety Projects Using Medicare Data University of Maryland Center of Excellence in Regulatory Science and Innovation (CERSI) Conference September 12, 2013 Sukhminder K. Sandhu, PhD, MPH,

More information

Inherent characteristics predisposing to reassortment & mutation

Inherent characteristics predisposing to reassortment & mutation Viral characteristics of H5N1 influencing mutation/reassortment events with pandemic potential FAO-OIE-WHO Scientific Consultation on Avian Influenza at the Human-Animal Interface Ruben Donis, Ph.D. Influenza

More information

Studying Repeated Immunization in an Animal Model. Kanta Subbarao Laboratory of Infectious Diseases, NIAID

Studying Repeated Immunization in an Animal Model. Kanta Subbarao Laboratory of Infectious Diseases, NIAID Studying Repeated Immunization in an Animal Model Kanta Subbarao Laboratory of Infectious Diseases, NIAID Animal models in Influenza Research Commonly used Mice Ferrets Guinea pigs Non human primates Less

More information

H5N1 and H7 LAIV-IAV Prime-Boost Studies

H5N1 and H7 LAIV-IAV Prime-Boost Studies NIAID H5N1 and H7 LAIV-IAV Prime-Boost Studies Kanta Subbarao, MD, MPH NIAID, NIH The LID Pandemic Influenza Vaccine Program Program: CRADA with MedImmune Clinical Trials: Center for Immunization Research,

More information

Weekly Influenza & Respiratory Activity: Statistics Summary

Weekly Influenza & Respiratory Activity: Statistics Summary Weekly Influenza & Respiratory Activity: Statistics Summary 2011-12 updated 7/12/12 Influenza Activity in Minnesota Summary of the 2011-12 Season Since the start of the influenza season, 552 people were

More information

Crystal structure of the neutralizing antibody HK20 in complex with its gp41 antigen

Crystal structure of the neutralizing antibody HK20 in complex with its gp41 antigen Crystal structure of the neutralizing antibody HK20 in complex with its gp41 antigen David Lutje Hulsik Unit for Virus Host Cell Interaction UMI 3265 University Joseph Fourier-EMBL-CNRS, Grenoble Env catalyzed

More information

Summary of Data Dissemination Working Group. 22Jan2016

Summary of Data Dissemination Working Group. 22Jan2016 Summary of Data Dissemination Working Group 22Jan2016 Overview Review of Data Dissemination Working Group Strategy for data dissemination Testing of model and submission process Systems Biology Centers

More information

Weekly Influenza Activity: Statistics Summary

Weekly Influenza Activity: Statistics Summary Weekly Influenza Activity: Statistics Summary 2010-11 updated 9/9/11 Summary of the 2010-11 Influenza Season Since the start of the influenza season, 215 schools reported outbreaks of ILI. Influenza Activity

More information

VIRUS PATHOGEN RESOURCE & INFLUENZA RESEARCH DATABASE EXERCISES

VIRUS PATHOGEN RESOURCE & INFLUENZA RESEARCH DATABASE EXERCISES VIRUS PATHOGEN RESOURCE & INFLUENZA RESEARCH DATABASE EXERCISES Table of Contents Exercise 1. Getting familiar with the ViPR site 1 Exercise 2. Searching sequences and exploring genome annotations 2 Exercise

More information

Viruses 2013, 5, ; doi: /v Letter

Viruses 2013, 5, ; doi: /v Letter Viruses 2013, 5, 2796-2802; doi:10.3390/v5112796 Letter OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Large Scale Genome Analysis Shows that the Epitopes for Broadly Cross-Reactive Antibodies

More information

Patterns of hemagglutinin evolution and the epidemiology of influenza

Patterns of hemagglutinin evolution and the epidemiology of influenza 2 8 US Annual Mortality Rate All causes Infectious Disease Patterns of hemagglutinin evolution and the epidemiology of influenza DIMACS Working Group on Genetics and Evolution of Pathogens, 25 Nov 3 Deaths

More information

Minimum Data Fields for Wild and Domestic Bird Surveillance Finalized October 3, 2008 by DMID/NIAID Updated April 30, 2010

Minimum Data Fields for Wild and Domestic Bird Surveillance Finalized October 3, 2008 by DMID/NIAID Updated April 30, 2010 Minimum Data Fields for Wild and Domestic Bird Surveillance Finalized October 3, 2008 by DMID/NIAID Updated April 30, 2010 ------------------------------------------------------------------------------------------------------------

More information

Influenza: Ecology and Continuing Evolution

Influenza: Ecology and Continuing Evolution Influenza: Ecology and Continuing Evolution Robert G. Webster, PhD Division of Virology Department of Infectious Diseases St. Jude Children s s Research Hospital Influenza Virus Negative sense RNA virus

More information

Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host

Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host Cell Host & Microbe, Volume 16 Supplemental Information Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host Andrew Varble, Randy A. Albrecht, Simone Backes, Marshall

More information

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood tree illustrating CRF01_AE gp120 protein sequence relationships between 107 Envs sampled in the RV144 trial

More information

Mutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey

Mutants and HBV vaccination. Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Mutants and HBV vaccination Dr. Ulus Salih Akarca Ege University, Izmir, Turkey Geographic Distribution of Chronic HBV Infection 400 million people are carrier of HBV Leading cause of cirrhosis and HCC

More information

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:

Biotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: Biotechnology-Based Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Objectives of this lecture By the end of this lecture you will be able to: 1.

More information

Dengue Update. Actualització sobre dengue

Dengue Update. Actualització sobre dengue Leading research at: Dengue Update Click to edit Master subtitle style Actualització sobre dengue Ned Hayes, MD Dengue Leading research at: Caused by infection with one of 4 viruses DEN-1, DEN-2, DEN-3,

More information

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist Identification of Mutation(s) in the HIV 1 gp41 Subunit Associated with Neutralization Resistance Miah Blomquist What is HIV 1? HIV-1 is an epidemic that affects over 34 million people worldwide. HIV-1

More information

Re-engineering HA as a strategy to develop universal influenza vaccines

Re-engineering HA as a strategy to develop universal influenza vaccines WHO Integrated Meeting on Development & Clinical Trials of Influenza Vaccines Re-engineering HA as a strategy to develop universal influenza vaccines Harry Kleanthous, Ph.D. Discovery Research January

More information

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA David L. Suarez Southeast Poultry Research Laboratory, Exotic and Emerging Avian Viral Diseases Research

More information

Intraseasonal Dynamics and Dominant Sequences in H3N2 Influenza

Intraseasonal Dynamics and Dominant Sequences in H3N2 Influenza Intraseasonal Dynamics and Dominant Sequences in H3N2 Influenza Nicole Creanza 1., Jason S. Schwarz 1. *, Joel E. Cohen 1,2 1 Laboratory of Populations, Rockefeller University, New York, New York, United

More information

Influenza. By Allison Canestaro-Garcia. Disease Etiology:

Influenza. By Allison Canestaro-Garcia. Disease Etiology: Influenza By Allison Canestaro-Garcia Disease Etiology: The flu is an infectious disease caused by a subset of viruses of the family Orthomyxoviridae. There are 7 different viruses in this family, four

More information

PROTOCOL FOR INFLUENZA A VIRUS GLOBAL SWINE H1 CLADE CLASSIFICATION

PROTOCOL FOR INFLUENZA A VIRUS GLOBAL SWINE H1 CLADE CLASSIFICATION PROTOCOL FOR INFLUENZA A VIRUS GLOBAL SWINE H1 CLADE CLASSIFICATION January 23, 2017 1. Background Swine H1 viruses have diversified into three major genetic lineages over time. Recently, Anderson et al.

More information

Synthetic Genomics and Its Application to Viral Infectious Diseases. Timothy Stockwell (JCVI) David Wentworth (JCVI)

Synthetic Genomics and Its Application to Viral Infectious Diseases. Timothy Stockwell (JCVI) David Wentworth (JCVI) Synthetic Genomics and Its Application to Viral Infectious Diseases Timothy Stockwell (JCVI) David Wentworth (JCVI) Outline Using informatics to predict drift (strain selection) Synthetic Genomics: Preparedness

More information

Sequence Analysis of Human Immunodeficiency Virus Type 1

Sequence Analysis of Human Immunodeficiency Virus Type 1 Sequence Analysis of Human Immunodeficiency Virus Type 1 Stephanie Lucas 1,2 Mentor: Panayiotis V. Benos 1,3 With help from: David L. Corcoran 4 1 Bioengineering and Bioinformatics Summer Institute, Department

More information

Transmission Bottleneck Size Estimation from Pathogen Deep- Sequencing Data, with an Application to Human Influenza A Virus

Transmission Bottleneck Size Estimation from Pathogen Deep- Sequencing Data, with an Application to Human Influenza A Virus JVI Accepted Manuscript Posted Online 3 May 2017 J. Virol. doi:10.1128/jvi.00171-17 Copyright 2017 Sobel Leonard et al. This is an open-access article distributed under the terms of the Creative Commons

More information

Finding protein sites where resistance has evolved

Finding protein sites where resistance has evolved Finding protein sites where resistance has evolved The amino acid (Ka) and synonymous (Ks) substitution rates Please sit in row K or forward The Berlin patient: first person cured of HIV Contracted HIV

More information

Development of a predictive model for vaccine matching for serotype O FMDV from serology and capsid sequence

Development of a predictive model for vaccine matching for serotype O FMDV from serology and capsid sequence Development of a predictive model for vaccine matching for serotype O FMDV from serology and capsid sequence D. Borley, S. Upadhyaya, D. Paton, R. Reeve and Mana Mahapatra Pirbright Laboratory United Kingdom

More information

FMD Vaccine Strain Selection

FMD Vaccine Strain Selection FMD Vaccine Strain Selection David Paton, Pirbright, UK New Delhi, 13-15 February 2012 Conclusions Vaccine match is one component of vaccine efficacy Vaccine quality may compensate for imperfect match

More information

Identifying, Preparing for & Reducing Pandemic Risk

Identifying, Preparing for & Reducing Pandemic Risk Identifying, Preparing for & Reducing Pandemic Risk Jonna Mazet, DVM, MPVM, PhD Professor of Epidemiology & Disease Ecology One Health Institute School of Veterinary Medicine University of California,

More information

Final Report. Identification of Residue Mutations that Increase the Binding Affinity of LSTc to HA RBD. Wendy Fong ( 方美珍 ) CNIC; Beijing, China

Final Report. Identification of Residue Mutations that Increase the Binding Affinity of LSTc to HA RBD. Wendy Fong ( 方美珍 ) CNIC; Beijing, China Final Report Identification of Residue Mutations that Increase the Binding Affinity of LSTc to HA RBD Wendy Fong ( 方美珍 ) CNIC; Beijing, China Influenza s Viral Life Cycle 1. HA on virus binds to sialic

More information

Infectious Disease Ontology

Infectious Disease Ontology Infectious Disease Ontology Lindsay G. Cowell, PhD Associate Professor Division of Biomedical Informatics Department of Clinical Sciences UT Southwestern Medical Center GOALS Coverage of the entire infectious

More information

Virus Panels for Assessing Vaccine-Elicited Neutralizing Antibodies

Virus Panels for Assessing Vaccine-Elicited Neutralizing Antibodies Virus Panels for Assessing Vaccine-Elicited Neutralizing Antibodies Michael Seaman, Ph.D. Center for Virology and Vaccine Research Beth Israel Deaconess Medical Center Harvard Medical School J. Virol.

More information

Current CEIRS Program

Current CEIRS Program History The influenza program at St. Jude has a long, distinguished history as a world-class leader in the study of the origins, evolution, and pathogenesis of influenza viruses. Based on this expertise,

More information

YUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan

YUMI YAMAGUCHI-KABATA AND TAKASHI GOJOBORI* Center for Information Biology, National Institute of Genetics, Mishima , Japan JOURNAL OF VIROLOGY, May 2000, p. 4335 4350 Vol. 74, No. 9 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Reevaluation of Amino Acid Variability of the Human

More information

Epitope discovery and Rational vaccine design Morten Nielsen

Epitope discovery and Rational vaccine design Morten Nielsen Epitope discovery and Rational vaccine design Morten Nielsen mniel@cbs.dtu.dk Bioinformatics in a nutshell List of peptides that have a given biological feature Mathematical model (neural network, hidden

More information

Weekly Influenza & Respiratory Illness Activity Report

Weekly Influenza & Respiratory Illness Activity Report Weekly Influenza & Respiratory Illness Activity Report A summary of influenza surveillance indicators prepared by the Division of Infectious Disease Epidemiology Prevention & Control Week Ending March

More information